Orphan designation: Human IgG1 monoclonal antibody targeting amyloid transthyretin Treatment of ATTR amyloidosis, 19/02/2024 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 April 2024 - 13:06

Orphan designation: Human IgG1 monoclonal antibody targeting amyloid transthyretin Treatment of ATTR amyloidosis, 19/02/2024 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-24-2896

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters